In 2019, among 263 SSPs responding to an online survey, 247 (94%) had implemented OEND. The number of persons who received naloxone per opioid overdose death and the number of naloxone doses distributed per opioid overdose death during the previous year varied by census division (CDC)
Bibliography: All Publications
Access to take-home naloxone increased through paramedic supply
Ambulance paramedics are to supply to patients at risk of an opiate overdose take-home naloxone as part of a pilot scheme in Glasgow (SDF)
WHO cannabis rescheduling and its relevance for the Caribbean
Following its first-ever critical review of cannabis, in January 2019 the World Health Organization (WHO) issued a collection of formal recommendations to reschedule cannabis and cannabis-related substances. 53 member states of the Commission on Narcotic Drugs (CND), two of which are Caribbean states, are set to vote on these recommendations in December 2020 (tni)
ACMD work programme 2020 to 2022: commissioning letter
The Home Secretary’s commissioning letter to the chair of the Advisory Council on the Misuse of Drugs (ACMD) for the period 2020 to 2022
National Naloxone programme Scotland
This release by Public Health Scotland presents information on the number of take-home naloxone kits issued by the National Naloxone Programme in Scotlan
United Kingdom drug situation: Focal Point annual report
Annual report and data tables from the UK Focal Point on Drugs on the national prevalence, impact, prevention and treatment of drug use (PHE)
Facilitators and barriers to health care access amongst people using image and performance enhancing drugs in Wales
Building on the national surveys of image and performance enhancing drug use undertaken in both 2015 and 2016, a qualitative research project was undertaken in Wales to explore the barriers and facilitators to health care access amongst people using anabolicandrogenic steroids (AAS) and other image and performance enhancing drugs (Public Health Wales)
Enhancing the Criminal Court Response to Substance Misuse
Evidence and Practice Briefing (Centre for Justice Innovation)
Physicians’ progress toward ending the nation’s drug overdose and death epidemic
The nation’s continuing increase in drug overdoses is fuelling the evolution of a more dangerous and complicated epidemic (AMA)
Scottish Drug Deaths Taskforce: One Year Report
This report details the work and achievements of the Drug Deaths Taskforce following its establishment in July 2019
United Kingdom drug situation: Focal Point annual report
Annual report and data tables from the UK Focal Point on Drugs on the national prevalence, impact, prevention and treatment of drug use (Home Office)
NDCP Releases Data on Coca Cultivation and Production in Peru
Coca (the plant used to make cocaine) cultivation in Peru significantly increased to 72,000 hectares in 2019, with potential pure cocaine production of 705 metric tons (ONDCP)
Injecting equipment provision in Scotland
This release by Public Health Scotland presents information on the provision of injecting equipmen
Care for Veterans with Substance Use and Mental Health Disorders Requires Improvement
Veterans who have served in the U.S. military since the 9/11 attacks have a high level of need for both substance use treatment and mental health care, yet many do not receive appropriate help for their co-occurring disorders, according to a new RAND Corporation report
The new EU Agenda and Action Plan on Drugs 2021-2025
On the path toward building up its internal security, on 24 July 2020, the European Commission adopted a new EU Agenda and Action Plan on Drugs 2021-2025
Medicinal Use of Psilocybin: Reducing restrictions on research and treatment
The Adam Smith Institute, in conjunction with the Conservative Drug Policy Reform Group (CDPRG), has published a new report outlining the medical potential of psilocybin and the need to reduce restrictions on research and treatmen
A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report
This report describes the development of a national model of remote care to eliminate waiting lists and increase access to OAT in Ireland (BMC)
Provisional Drug Overdose Death Counts
This data visualization presents provisional counts for drug overdose deaths based on a current flow of mortality data in the National Vital Statistics System (CDC)
National Drug Strategy Household Survey 2019
This report presents key results from the 2019 National Drug Strategy Household Survey. It looks at people’s drug use throughout their lives and during the last 12 months, and examines how these patterns have changed over time (AIHW)
Summing it up: Building evidence to inform advocacy for harm reduction funding in Asia
Harm Reduction International developed tools for assessing national harm reduction investment and spending on drug law enforcement. This report presents the research findings generated by these tools in seven Asian countries. It provides insights on the state of harm reduction financing, informed by donor and government stakeholders, civil society and community representatives (HRI)
Youth Violence Commission Final Report (PDF)
While the magnitude of the effort needed to protect young people from serious violence cannot be underestimated, we believe there is cause for cautious optimism (YVC)
Prescription Opioids (Canadian Drug Summary)
Summarizes data on the use of prescription opioids, including information on associated harms and effects, legal status, costs, hospitalization, emergency department visits and access to treatment (CCSA)
Drug treatment in Ireland 2013 to 2019
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland (HRB)
Canadian Substance Use Costs and Harms (2015-2017)
This report provides a summary of key findings about the costs and harms of substance use in Canada from 2015 to 2017 (CCSA)
COVID-19, Prisons and Drug Policy
Detention settings are high-risk environments for the spread of infectious diseases. As such, COVID-19 has posed unprecedented challenges for governments and prison administrations, catalysing the uptake of exceptional measures around the world to decongest prisons (Harm Reduction International)
Saving Lives in the time of COVID-19
Case Study of Harm Reduction, Homelessness and Drug Use in Dublin, Ireland (LSE)
Review of literature on illegal drugs in the region
This document presents a summary of academic research papers on illegal drugs (CESED, Colombia)
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study
The Australians’ Drug Use: Adapting to Pandemic Threats (ADAPT) Study is exploring the short and long-term impact of the COVID-19 pandemic on the experiences of Australians who use illicit drugs (NDARC)
Addiction Services in Northern Ireland
This report provides an overview of the scale of alcohol and drug addiction in Northern Ireland, the structures and systems in place within the health sector for tackling addiction, and the challenges faced by those accessing addiction services (NIAO)
Drugs, Prisons and ‘Unintended Consequences’ – Does drug interdiction drive drug-related harms?
The availability and use of drugs in prisons cannot be separated from wider drug policy. The criminalisation of drugs and the people who use or sell them fuels mass incarceration in many countries, and in doing so creates large profitable markets for drugs behind bars (Gdpo)
Philippines: New report reveals deliberate killings of children during “war on drugs”
A new report, published today, documents 122 killings of children, from 1 to 17 years old, throughout the Philippines, between July 2016 and December 2019 (OMCT)
Drugs, Prisons and ‘Unintended Consequences’ – Does drug interdiction drive drug-related harms?
If governments are truly serious about addressing drug use and reducing drug-related harm, they must move away from enforcement-focussed responses, and instead implement laws and policies that reduce the number of people in prison for drug-related offences, and to provide comprehensive harm reduction programmes for people in detention (Global Drug Policy Observatory)
Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia
Preliminary findings from the Ecstasy and Related Drugs Reporting System 2020 (NDARC)
Alcohol and other drug treatment services in Australia, 2018–19
In 2018–19, 1,283 publicly funded alcohol and other drug (AOD) treatment services provided just under 220,000 treatment episodes to an estimated 137,000 clients (AIHW)
World Drug Report 2020
Presented in six separate booklets, the World Drug Report 2020 provides a wealth of information and analysis to support the international community in implementing operational recommendations on a number of commitments made by Member States, including the recommendations contained in the outcome document of the special session of the General Assembly on the world drug problem, held in 2016 (UNODC)
EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europe
This briefing provides a snapshot of the state of play with respect to the impact of COVID-19 on drug consumption patterns and drug-related harms during the early stages of the pandemic (EMCDDA)
Public Health and Safety Consequences of Liberalizing Drug Laws
Insights from Cannabis Legalization (RAND)
Original quantitative research – Setting the baseline
A description of cannabis poisonings at a Canadian pediatric hospital prior to the legalization of recreational cannabis (Public Health Agency of Canada)
Drug Decriminalization Policy (PDF)
Literature Review: Models, Implementation and Outcomes (Finnish institute for health and welfare)
Changes Related to COVID-19 in the Illegal Drug Supply and Access to Services, and Resulting Health Harms (PDF)
This alert is based on information collected by the Canadian Community Epidemiology Network on Drug Use (CCENDU) between March 31 and May 10, 2020. It focuses on the impact of containment efforts related to COVID-19 on the illegal drug supply and access to services, and the associated health harms
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 49
- Next Page »
